Literature DB >> 18250100

Identification of genetic variants that influence circulating IGF1 levels: a targeted search strategy.

Claire Palles1, Nichola Johnson, Ben Coupland, Claire Taylor, Jaime Carvajal, Jeff Holly, Ian S Fentiman, Isabel dos Santos Silva, Alan Ashworth, Julian Peto, Olivia Fletcher.   

Abstract

An important class of genetic variants that affect disease susceptibility may lie within regulatory elements that influence gene expression. Regulatory sequences are difficult to identify and may be distant from the genes they regulate, but many lie within evolutionarily conserved regions (ECRs). We used comparative genomics to identify 12 ECRs up to 75 kb 5' to and within introns of IGF1. These were screened by high-resolution melting curve analysis, and 18 single-nucleotide polymorphisms (SNPs) were identified, including five novel variants. We analysed two large population-based series of healthy women to test the nine SNPs with minor allele frequency (MAF) >1% within ECRs. Three of the nine SNPs within ECRs (rs35455143, rs35765817 and rs3839984) were significantly associated with circulating IGF1 levels in a multivariate analysis (P <or= 0.02 for each SNP, overall significance P < 0.001). All three are uncommon SNPs (MAF <or= 10%) that lie >70 kb 5' of IGF1. Two (rs35455143 and rs35765817) are in strong LD with each other and appear to have opposite effects on circulating IGF1. Our results on a subset of other SNPs in or near IGF1 were consistent with previously reported associations with IGF1 levels, although only one (rs35767: P = 0.05) was statistically significant. We believe that this is the first systematic study of an association between a phenotype and SNPs within ECRs extending over a large region adjacent to a gene. Targeting ECRs appears to be a useful strategy for identifying a subset of potentially functional non-coding regulatory SNPs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18250100     DOI: 10.1093/hmg/ddn034

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  18 in total

1.  Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population.

Authors:  Kimberly E Alexander; Suzanne Chambers; Amanda B Spurdle; Jyotsna Batra; Felicity Lose; Tracy A O'Mara; Robert A Gardiner; Joanne F Aitken; Judith A Clements; Mary-Anne Kedda; Monika Janda
Journal:  Qual Life Res       Date:  2015-02-28       Impact factor: 4.147

Review 2.  High resolution melting applications for clinical laboratory medicine.

Authors:  Maria Erali; Karl V Voelkerding; Carl T Wittwer
Journal:  Exp Mol Pathol       Date:  2008-04-13       Impact factor: 3.362

3.  Prospective study of insulin-like growth factor-I, insulin-like growth factor-binding protein 3, genetic variants in the IGF1 and IGFBP3 genes and risk of coronary artery disease.

Authors:  Sally L Ricketts; Katrijn L Rensing; Jeff M Holly; Li Chen; Elizabeth H Young; Robert Luben; Sofie Ashford; Kijoung Song; Xin Yuan; Abbas Dehghan; Benjamin J Wright; Dawn M Waterworth; Vincent Mooser; Gérard Waeber; Peter Vollenweider; Stephen E Epstein; Mary S Burnett; Joseph M Devaney; Hakon H Hakonarson; Daniel J Rader; Muredach P Reilly; John Danesh; Simon G Thompson; Alison M Dunning; Cornelia M van Duijn; Nilesh J Samani; Ruth McPherson; Nicholas J Wareham; Kay-Tee Khaw; S Matthijs Boekholdt; Manjinder S Sandhu
Journal:  Int J Mol Epidemiol Genet       Date:  2011-08-03

4.  IGF1 htSNPs in relation to IGF-1 levels in young women from high-risk breast cancer families: implications for early-onset breast cancer.

Authors:  Maria Henningson; Maria Hietala; Therese Törngren; Håkan Olsson; Helena Jernström
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

5.  Assessment of age-related changes in heritability and IGF-1 gene effect on circulating IGF-1 levels.

Authors:  Liran Franco; Frances M K Williams; Svetlana Trofimov; Ida Malkin; Gabriela Surdulescu; Timothy Spector; Gregory Livshits
Journal:  Age (Dordr)       Date:  2014-02-04

6.  Bladder cancer SNP panel predicts susceptibility and survival.

Authors:  Angeline S Andrew; Jiang Gui; Arthur C Sanderson; Rebecca A Mason; Elaine V Morlock; Alan R Schned; Karl T Kelsey; Carmen J Marsit; Jason H Moore; Margaret R Karagas
Journal:  Hum Genet       Date:  2009-03-01       Impact factor: 4.132

7.  A polymorphism near IGF1 is associated with body composition and muscle function in women from the Health, Aging, and Body Composition Study.

Authors:  Matthew C Kostek; Joseph M Devaney; Heather Gordish-Dressman; Tamara B Harris; Paul D Thompson; Priscilla M Clarkson; Theodore J Angelopoulos; Paul M Gordon; Niall M Moyna; Linda S Pescatello; Paul S Visich; Robert F Zoeller; Richard L Seip; Melissa Garcia; Rongling Li; Joseph M Zmuda; Matthew J Delmonico; Alka Kanaya; Eric P Hoffman
Journal:  Eur J Appl Physiol       Date:  2010-05-19       Impact factor: 3.078

8.  A multi-cohort study of polymorphisms in the GH/IGF axis and physical capability: the HALCyon programme.

Authors:  Tamuno Alfred; Yoav Ben-Shlomo; Rachel Cooper; Rebecca Hardy; Cyrus Cooper; Ian J Deary; Tom R Gaunt; David Gunnell; Sarah E Harris; Meena Kumari; Richard M Martin; Avan Aihie Sayer; John M Starr; Diana Kuh; Ian N M Day
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

9.  Genetic and Epigenetic Modulation of Growth Hormone Sensitivity Studied With the IGF-1 Generation Test.

Authors:  Meriem Ouni; Anne-Laure Castell; Agnès Linglart; Pierre Bougnères
Journal:  J Clin Endocrinol Metab       Date:  2015-04-02       Impact factor: 5.958

10.  The IGF1 P2 promoter is an epigenetic QTL for circulating IGF1 and human growth.

Authors:  Meriem Ouni; Yasemin Gunes; Marie-Pierre Belot; Anne-Laure Castell; Delphine Fradin; Pierre Bougnères
Journal:  Clin Epigenetics       Date:  2015-03-13       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.